Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Proteases, proteolysis, and apoptosis

E Solary1, B Eymin, N Droin

  • 1Department of Biology and Therapy of Cancer, CJF INSERM 94-08, Faculty of Medicine, Dijon, France.

Cell Biology and Toxicology
|April 29, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Targeting the spliceosome: A new therapeutic strategy to counteract chemotherapy resistance in lung cancer?]

Revue des maladies respiratoires·2024
Same author

Moving toward precision oncology centers V2.0.

Annals of oncology : official journal of the European Society for Medical Oncology·2023
Same author

Retraction Note: p14<sup>ARF</sup> promotes RB accumulation through inhibition of its Tip60-dependent acetylation.

Oncogene·2023
Same author

Correction to: p14<sup>ARF</sup> inhibits the growth of lung adenocarcinoma cells harbouring an EGFR L858R mutation by activating a STAT3-dependent pro-apoptotic signalling pathway.

Oncogene·2021
Same author

Whole exome sequencing in molecular diagnostics of cancer decreases over time: evidence from a cost analysis in the French setting.

The European journal of health economics : HEPAC : health economics in prevention and care·2021
Same author

Outcome and molecular landscape of patients with PIK3CA-mutated metastatic breast cancer.

Annals of oncology : official journal of the European Society for Medical Oncology·2020

Caspases, aspartate-specific cysteine proteases, are key enzymes in apoptosis, cleaving cellular proteins. Inhibiting these proteases shows therapeutic potential in liver destruction.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Cell Biology

Background:

  • Apoptosis involves specific proteolytic cleavage of cellular proteins.
  • Caspases, aspartate-specific cysteine proteases, are the primary enzymes mediating this cleavage.
  • Over ten human caspase homologues, including interleukin-1 beta converting enzyme (ICE), have been identified.

Purpose of the Study:

  • To review the role of caspases in apoptosis.
  • To discuss caspase structure, substrate specificity, and activation mechanisms.
  • To explore other proteolytic pathways involved in apoptosis and therapeutic implications.

Main Methods:

  • Review of existing literature on caspases and apoptosis.
  • Analysis of caspase structure and substrate requirements.

Related Experiment Videos

  • Discussion of proposed caspase activation cascades and related proteolytic pathways.

    • Main Results:

    • Caspases are active as heterodimers derived from inactive precursors.
    • Caspase activity requires a tetrapeptide substrate with an aspartate at P1.
    • Protease inhibitors can prevent acute liver destruction, suggesting therapeutic efficacy.

    Conclusions:

    • Caspase-mediated proteolysis is central to apoptosis.
    • Understanding caspase substrate specificity and activation is crucial.
    • Targeting cell death-associated proteolysis offers a viable therapeutic strategy.